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Abstract: Since the early nineties countless publications have reported promising medicinal applications
for [60]fullerene (C60) related to its unparalleled affinity towards free radicals. Yet, until now no officially
approved C60-based drug has reached the market, notably because of the alleged dangers of C60.
Nevertheless, since the publication of the effects of C60 on the lifespan of rodents, a myriad of companies
started selling C60 worldwide for human consumption without any approved clinical trial. Nowadays,
several independent teams have confirmed the safety of pure C60 while demonstrating that previously
observed toxicity was due to impurities present in the used samples. However, a purity criterion for C60
samples is still lacking and there are no regulatory recommendations on this subject. In order to avoid
a public health issue and for regulatory considerations, a quality-testing strategy is urgently needed. Here
we have evaluated several analytical tools to verify the purity of commercially available C60 samples.
Our data clearly show that differential scanning calorimetry is the best candidate to establish a purity
criterion based on the sc-fcc transition of a C60 sample (Tonset ≥ 258 K, ∆sc-fccH ≥ 8 J g−1).
Keywords: fullerene; C60; purity; differential scanning calorimetry (DSC); gas chromatography mass
spectrometry (GC-MS); nanomaterials; nanomedicine
1. Introduction
Since the early nineties of the last century [60]fullerene (C60) [1], the most abundant fullerene,
has attracted intense interest in the field of biomedical applications [2–6] due to its unique properties.
Dozens of well-characterized C60-derivatives have been synthetized and proposed for many biomedical
applications [2–10]. The first review on this subject published more than 20 years ago already depicted
all the potential biomedical applications, thus predicting that fullerenes would lead to a large panel of
new drug candidates [6].
One of the most investigated properties in the field of biomedical applications is the unparalleled
affinity of C60 for radicals [7,8]. The reported activities for C60 and its derivatives during the last two decades
range from anti-inflammatory and anti-allergic effects to protection against ionizing-radiation-induced
mortality and neuroprotection, through limitation of acne vulgaris and even the potentiation of hair
growth [2,3]. Most of these beneficial effects are related to its ability to scavenge free radicals. Indeed,
several independent teams from different countries, using a large panel of experimental models, have
demonstrated that various synthetic compounds with the C60 moiety in common can promote and sustain
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good health [2–10] whilst pristine C60 itself could extend the expected lifespan of mammals [11]. What,
then, prevents all these promising applications from becoming reality [12]? What prevents legal C60-based
drugs? In fact, the main obstacle is concern about fullerene toxicity raised by some studies conducted
with contaminated fullerene samples (see for instance the commentary in Figure S1 of the Supplementary
Materials). Indeed, it has been clearly shown that tetrahydrofuran decomposition products are responsible
for the observed toxicity of C60-samples, when tetrahydrofuran is used as a co-solvent to prepare C60
aqueous suspensions [13]. Two years later another independent research team confirmed that pure C60 is
not toxic [14]. Meanwhile, a series of tests conducted by several independent teams have confirmed the
safety of pure C60 in a large panel of experimental models encompassing different clades [13–15].
Nevertheless, an officially certified toxicity test is still lacking. Also, C60 aggregates may convey
toxic elements as any other aggregated material [13–15]. Yet, since the publication of the effects of C60
on the lifespan of rats [11], a myriad of start-ups has started selling C60 oily solutions on a worldwide
scale for human consumption without any existing formal oversight [16].
In order to avoid any new toxicity alerts like the ones that occurred in 2004 [17], which would
definitively condemn the use of such a promising material in the biomedical realm, a quality-testing
strategy is urgently needed. To this purpose, it is of importance to define a purity criterion for C60
and to develop simple tools to check the purity of C60 samples. Although it is obvious for drug
candidates to fulfill a certain set of quality requirements, a purity assessment also falls squarely in the
realm of R.E.A.C.H. (Registration, Evaluation, Authorization and restriction of Chemicals), a European
regulation “adopted to improve the protection of human health and the environment from risks that
can be posed by chemicals” [18].
In this study, we used several methods to assess C60 purity both in the solid state and in
solution. Solid-state investigations include electron microscopy (SEM), high-resolution X-ray powder
diffraction (HR-XRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA),
and Fourier-transform infrared spectroscopy (FTIR). To assess the presence of impurities through
solution and the gas phase, we used reversed-phase high-pressure liquid chromatography (RP-HPLC),
gas chromatography coupled to mass spectrometry (GC-MS), and UV–Vis spectrophotometry.
The combination of all these techniques was applied to compare the purity of four C60 samples
from different origins.
The main objective of this work was to select the best and easiest method(s) to verify the purity of
a C60 sample with the aim of establishing a validation tool for C60 used as an active pharmaceutical
ingredient (API).
2. Materials and Methods
2.1. Chemicals
Commercial C60 samples with different degrees of purity as specified by the manufacturers:
S1 (99.98%); S2 (>99.98%); S3 (99.9%); and S4 (99.5%) were used for this study.
Toluene was obtained from Merck (Darmstadt, Germany) and acetonitrile from Carlo Erba (Val-de-Reuil,
France). Both solvents were of high purity grade (99.9%) and were used without further purification.
2.2. Scanning Electron Microscopy
Electron microscopy images were obtained using a Hitachi TM-1000 (Tokyo, Japan) tabletop
scanning electron microscope with a scanning voltage of 15 kV. To improve the quality of C60 sample
images, their surface was coated with a thin layer of gold.
2.3. High Resolution X-Ray Powder Diffraction
X-ray powder diffraction was carried out on a transmission mode diffractometer using
Debye-Scherrer geometry equipped with cylindrical position sensitive detectors (CPS120) from
INEL (Artenay, France) containing 4096 channels (0.029◦ 2θ angular step) with monochromatic Cu Kα1
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(λ = 1.5406 Å) radiation. Unground specimens were introduced in a Lindemann capillary (0.5 mm
diameter) rotating perpendicularly to the X-ray beam during the experiments to improve the average
over the crystallite orientations. All samples were measured at 300 K for at least one hour. External
calibration using the Na2Ca2Al2F14 cubic phase mixed with silver behenate was performed by means
of cubic spline fittings. The XRD patterns data were analyzed with FullProf v2.05.18 [19].
2.4. Energy Dispersive X-Ray Spectroscopy (EDS) and Energy Dispersive X-Ray Fluorescence (EDF)
Energy dispersive X-ray spectroscopy (EDS) was carried out with a JEOL JSM-7001F field emission
scanning electron microscope (Tokyo, Japan) and an X-Max SDD (silicon drift detector) from Oxford
Instruments (Abingdon, UK).
Energy dispersive X-ray fluorescence (EDF) was carried out in a helium atmosphere with a Panalytical
Epsilon 3XL (Royston, U.K.) equipped with an X-ray tube containing an Ag anode. The C60 powder was
in the first instance deposited on a Prolene membrane. For quantitative measurements, a suspension of
0.955 g L−1 of C60 in demineralized water was deposited in quantities of 20 µL (representing 19.1 µg of
C60) on a polycarbonate membrane. The measurement was carried out after complete evaporation of the
water. A control containing only demineralized water was analyzed too.
2.5. Differential Scanning Calorimetry (DSC)
DSC measurements at normal pressure were performed by means of a Q100 thermal analyzer from
TA Instruments (New Castle, DE, USA) under He flux at cooling then heating rates of 5 K min−1 in the
temperature range from 303 K to 213 K. Sample masses (≈5 mg) were weighed with a microbalance
sensitive to 0.01 mg and sealed in aluminum pans of 30 mL inner volume. Indium was used as a standard
for the calibration of temperature and enthalpy change.
2.6. Thermogravimetric Analysis
Thermogravimetric measurements were performed by means of a Q50 system from TA Instruments
(New Castle, DE, USA) under nitrogen flux from room temperature to 673 K. Heating rates of 10 K·min−1
and sample masses of ca. 5 mg were used.
2.7. Fourier Transform Infrared Spectroscopy (FTIR)
FTIR analyses were performed on tablet transmission sampling mode. Tablets were prepared by
mixing ~1 mg of C60 sample powder with 10 mg of KBr powder and then analyzed in a PerkinElmer
Frontier IR/FIR (Perkin ELMER, Villebon-sur-Yvette, France) instrument in 400–4000 cm−1 ranges.
2.8. Reversed-Phase High-Pressure Liquid Chromatography Coupled to Diode Array Detection
Chromatographic analyses were performed as previously described [20] with minor modifications.
We used a longer column (25 cm instead of 12.5 cm) packed with the same stationary phase in order to
better separate possible impurities eluting before C60. The mobile phase consisted of a mixture of
toluene/acetonitrile (42/58, v/v) and was delivered by a P100 Spectra-System pump connected to
a UV6000 LP diode array detector (Thermo Spectra-System LC, Les Ulis, France). All chromatographic
analyses were performed at 30 ◦C with a flow rate of 0.8 mL/min.
Working solutions of 1 mg/L, 2 mg/L, 5 mg/L, and 45 mg/L were prepared daily by appropriate
dilution of the stock solution (100 mg/L) in the mobile phase before injection of 20 µL into the HPLC
system (n = 6 injections for each solution and every day for 6 days).
2.9. UV-Vis Spectrophotometry
For the UV-Vis spectrophotometry, stock solutions (100 mg/L) were prepared by dissolving each C60
sample in toluene. After stirring for 3 days, working solutions of 8 mg/L and 50 mg/L were prepared
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daily after appropriate dilution in toluene and scanned (300 nm to 700 nm) by an Agilent Varian 50 Bio
spectrophotometer (Santa Clara, CA, USA). Direct detection was recorded at 336 nm and 407 nm.
2.10. Gas Chromatography Coupled to Mass Spectrometry
Two measurement series were carried out with GC-MS, using the headspace trap (HS) method
(Perkin ELMER, Villebon-sur-Yvette, France). C60 impurities were analyzed by an HS trap coupled to
a Clarus 680 GC/MS platform equipped with a 30 m × 0.25 mm × 0.25 µm Elite-5MS column (Perkin
ELMER, Villebon-sur-Yvette, France). C60 powder was placed in a closed vial, which was loaded into
a thermostatic oven and heated at 160 ◦C for 20 min. A needle was then lowered into the headspace of
the vial, which was pressurized with He as a carrier gas at 35 psi for 1.5 min. While the needle was still
in the vial, the carrier flow to the vial was interrupted and by lack of external pressure, the already
pressurized headspace vapor was forced to escape through the needle and the trap at 40 ◦C, where the
volatile compounds were collected and focused. This was repeated 4 times, removing practically the
entire volatile compounds from the sample vial. The trap was then heated to 280 ◦C at 20 psi sweeping
the desorbed analytes out of the trap and into the Elite-5MS column at 10 psi for GC analysis. For GC
separation, the oven was heated from 40 ◦C to 220 ◦C with a heating rate of 4 ◦C min−1. The Clarus MS
was controlled via TurboMass™5.1 GC/MS software and operated in electron ionization (EI) mode
(transfer-line temp: 200 ◦C, electron energy: 70 eV, detector voltage: 400 V, mass range: 30–300 amu,
scan time: 0.41 sec, inter-scan delay: 0.01 sec).
2.11. Statistical Analysis
All statistical analyses were performed using one-way ANOVA test with a 95% confidence interval
(Graphpad prism 7, Graphpad software, San Diego, CA, USA), and a p-value of 0.05 (or less) was
considered statistically significant (for at least n = 6).
3. Results
3.1. Solid-State Studies
3.1.1. Morphology of The Samples
The four investigated C60 samples—S1, S2, S3, and S4—consist of fine powders exhibiting dark
grey to black color for the S1, S2, and S4 samples or a clear brownish hue for the S3 sample. In order to
further investigate their crystallinity we examined the samples by electron microscopy.
SEM photographs (Figure 1) show that the C60 particles of all the samples exhibit the usual
shapes [21–23] of face-centered cubic C60 microcrystals (i.e., twinned cuboctahedra with well-developed
(111) faces while the (100) faces are mostly absent).
Closer analysis revealed that samples S1 and S2 consist of grains of nearly uniform size of about
150 µm in diameter. For samples S3 and S4, the size distribution is much more polydisperse containing
grains of various sizes and particles of 1 µm or less in diameter adsorbed at the crystal surfaces.
In particular, in sample S4 aggregates of small cubic crystallites are observed (Figure 1).
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Figure 1. Scanning electron microscopy photographs of crystalline C60 powders of samples S1, S2, S3, 
and S4 with different magnifications. The inset shows the photograph of an aggregate of C60 crystals 
found in sample S4. 
3.1.2. Crystallographic Studies 
Figure 2 shows the high-resolution X-ray powder diffraction (XRD) patterns of the four samples 
obtained at 300 K. 
All samples exhibit the same profile as far as the peak positions are concerned, and the 
difference, if any, consists of small changes in relative intensities probably due to preferred 
orientation of the unground crystallites introduced in the Lindemann capillaries. In addition, it can 
be observed that sample S3 may contain some amorphous material or very small crystals as a slight 
Figure 1. Scanning electron microscopy photographs of crystalline C60 powders of samples S1, S2, S3,
and S4 with different magnifications. The inset shows the photograph of an aggregate of C60 crystals
found in sample S4.
3.1.2. Crystallographic Studies
Figure 2 shows the high-resolution X-ray powder diffraction (XRD) patterns of the four samples
obtained at 300 K.
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14.1829(7) Å, S3: 14.1950(12) Å, and S4: 14.1707(11) Å. 
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acquisition time of at least one h, large amounts of crystalline impurities in the form of solvates are 
clearly not present, although small amounts below the detection limit of 1% cannot be excluded. 
Moreover, comparing the obtained lattice parameters with those of C60O reported in the literature 
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epoxides should be investigated by other techniques. Hence, with XRD, it can be confirmed that no 
Figure 2. High-resolution X-ray powder diffraction patterns of samples S1, S2, S3, and S4, obtained
at 300 K. The arrows in the inset show how stacking faults and impurities modify the profile of the
111 reflection.
All samples exhibit the same profile as far as the peak positions are concerned, and the difference,
if any, consists of small changes in relative intensities probably due to preferred orientation of the
unground crystallites introduced in the Lindemann capillaries. In addition, it can be observed that
sample S3 may contain some amorphous material or very small crystals as a slight amorphous halo
can be observed around 20◦ 2θ (the step observed at 4◦ 2θ is due to alignment of the diffractometer).
The four diffraction patterns are identical to the theoretical pattern. Moreover, none of these
four patterns exhibits the “asymmetric ‘shoulder’ superimposed on the normal (111) Bragg reflection”
described previously and frequently ascribed to stacking faults and/or residual impurities by several
authors [24–26].
The lattice parameter of fcc C60 at 300 K has been refined for each sample using the pattern matching
tool of the FullProf program [19]. It led to the following values: S1: 14.1747(9) Å, S2: 14.1829(7) Å,
S3: 14.1950(12) Å, and S4: 14.1707(11) Å.
As the level of crystalline impurity observed by this technique can be as low as 1% for an acquisition
time of at least one h, large amounts of crystalline impurities in the form of solvates are clearly not present,
although small amounts below the detection limit of 1% cannot be excluded. Moreover, comparing
the obtained lattice parameters with those of C60O reported in the literature (a/Å ≈ 14.15 − 14.21) [27],
it is clear that the presence of C60 epoxide in the fcc lattice of C60 cannot be excluded as a result of the
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insignificant difference in unit-cell parameters. The presence of some C60 epoxides should be investigated
by other techniques. Hence, with XRD, it can be confirmed that no significant amount of crystalline
impurities was present, however sample S3 contained some amorphous (non-crystalline) material.
3.1.3. Trace Analysis in the Solid State
All four samples were analyzed by EDS. No other elements were found in samples S1, S2, and S3,
other than carbon and a trace of oxygen (Figure S2 of the Supplementary Materials). In sample S4,
small particles containing sulfur were observed. To quantify this finding EDF was used. A simple dry
deposit analyzed by EDF indicated the presence of sulfur and a trace amount of iron. Using liquid
suspensions as described in the experimental section, it was found that the sample contained 0.36%
of sulfur and 0.08% of iron. After multiple deposits, the presence of copper and chromium could be
observed, but these quantities were below the limits of quantification (Figure S3 of the Supplementary
Materials). It is most likely that the sulfur is a residue of carbon disulfide, in which C60 is relatively
soluble and which could have been used as a solvent for processing. Iron and the traces of copper and
chromium were most likely due to stainless steel equipment used to process the C60.
3.1.4. Calorimetric Results
Figure 3 shows the results obtained from heating the four studied samples and the temperature
and enthalpy changes with uncertainties of ±1 K and ±5% of the enthalpy value are summarized in
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Table 1. Temperature and enthalpy changes.
Samples Tonset/◦C (K) ∆H/J g−1
S1 −15.1 (258.0) 8.4
S2 −13.1 (260.0) 9.2
S3 −18.5 (254.6) 6.8
S4 −15.9 (257.2) 6.9
Although the melting temperature of fcc C60 remains unknown, because it sublimes or decomposes
before melting, early DSC studies have shown that a first-order transition into a simple cubic (sc)
structure occurs on cooling, which reverts back to the fcc phase at 257.1 K on reheating [28,29]. Using
a large single crystal, it was found that the onset temperature of this transition occurs at 261.4 K
with an enthalpy change of 9.0 ± 0.5 kJ mol−1 (12.5 ± 0.7 J g−1) including a 2.2 kJ mol−1 (3 J g−1)
pre-transitional effect starting at about 220 K. If the pre-transitional effect is not considered, the enthalpy
change of the endothermic peak at 261.4 K was found to be 6.8 kJ mol−1 (9.5 ± 0.7 J g−1).
Considering that enthalpy changes and an onset temperature closest to the result for the single
crystal are indicative of a higher purity, it can be concluded that samples S1 and S2 clearly have a higher
purity than the other two samples S3 and S4. For S3, the decrease in enthalpy fits the XRD observation
of the presence of amorphous material, although the lowering of the transition temperature also points
to the presence of impurities; whereas in the case of S4, a possible presence of impurities, such as the
sulfur observed by EDS and EDF, may explain the lowering of the value of the transition enthalpy.
3.1.5. Thermogravimetric Results
Thermogravimetric measurements were run from room temperature to 673 K. C60 samples were
placed in pierced aluminum pans and an empty pan was used as a control. It can be seen (Figure 4)
that no significant weight loss occurs up to about 600 K with S1, S2, and S3. In contrast, sample S4
exhibits a sudden weight loss of about 2% in the 350−450 K range that can be ascribed to molecular
materials with a relatively high vapor pressure, which are most likely residual solvents trapped in the
fcc lattice. The weight loss of about 1% in the 600−650 K range observed for S1 cannot be explained
by the loss of residual solvent, since volatile organic solvents used to extract and purify C60, when
trapped in the fcc lattice, are known to leave the C60 lattice in the temperature range of 300−450 K.
Thus, TGA experiments confirm that samples S1 and S2 possess a high purity. The fact that no
mass loss was found for sample S3, which clearly contains impurities following the DSC results, can
tentatively be explained by impurities composed of polymer-like C60 substances, possibly induced by
light exposure or by volatile impurities that leave at the very beginning of the experiment, when the
TGA balance is still stabilizing [30]. The presence of volatile impurities is confirmed for sample S4.
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Figure 4. Thermogravimetric curves obtained with samples S1, S2, S3, S4, and an empty pan at a heating
rate of 10 K min−1.
3.1.6. Infrared Spectroscopy
To investigate, in particular, the impurities of sample S3 in the solid state, also in relation to its
clear brownish hue, FTIR was used. FTIR was used before to compare the purity of C60 samples and
the presence of additional peaks in C60 spectra was reported for certain samples [31,32].
Figure 5 shows the representative spectra of the samples S1 and S3. The peaks at 526 cm−1,
575 cm−1, 1181 cm−1, and 1427 cm−1 correspond to C60 vibrations (Figure 5A) [33,34].
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What is worth noting however is that both samples exhibit additional peaks at 2850–3000 cm−1,
which can be ascribed to saturated C–H bonds [35], as well as some peaks at 796 cm−1, 1044 cm−1,
and 1259 cm−1, which can be ascribed to methyl-siloxane derivatives [36]. Moreover, for sample S3,
additional peaks at 669 cm−1, 738 cm−1, 775 cm−1, and 802 cm−1 most likely related to aromatic C–H
vibrations (Figure 5B) were also observed. These latter peaks closely correspond to those typical for
toluene and xylene [35], indicating that despite the absence of weight loss, sample S3 contains small
amounts of aromatic solvents, whereas sample S1 does not.
3.2. Solution- and Gas-Phase-Based Studies
3.2.1. UV-Vis Spectroscopy
Considering that impurities that interact with C60 could affect the molar absorptivity of
C60-samples, UV-Vis spectroscopy should be considered as one of the simplest tools to check the purity
of a C60-sample.
Figure 6A shows the representative UV-Vis spectrum of a toluene solution of the studied
samples. The observed spectral features agree with those previously observed by other authors [37,38].
The absence of absorption bands at 424 nm and 496 nm, characteristic of C60O [39], clearly indicates
that this impurity can only be present at concentrations below the limit of detection.
Figure 6C shows the comparison between the calculated molar absorptivity of each sample at
336 nm. The obtained data clearly demonstrates that while there is a significant difference between
samples S1 and S3, and S2 and S3, there is no significant difference between sample S4 and the three
other samples, probably because of the low conce tratio of the impurities in the latter. The within-run
(n = 6) and between-run (n = 6) precisions of the method under the selected conditions are 0.1% and
0.5%, respectively. Hence, more precision is needed for UV-Vis comparison of these samples. Further
analyses in other solvents with a lower UV cutoff such as hexane or methanol may provide additional
information in the UV region [40,41]; however, C60 is sparingly soluble in these solvents and therefore
high-precision results may be difficult to obtain for the impurities present at a very low concentration.
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3.2.2. High-Pressure Liquid Chromatography (HPLC)
HPLC is commonly used to check the purity of C60 samples, notably in order to check the presence
of higher fullerenes and/or C60 derivatives. Hence, we analyzed the samples by HPLC coupled to
diode array detection with a previously validated method [20] and a minor modification. Notably,
we doubled the column length in order to enhance the resolution, thus improving the separation of
possible impurities eluting before C60. Such impurities may include peaks corresponding to more
polar compounds such as oxide derivatives. However, other aromatic compounds such as benzene
and anthracene derivatives cannot be detected under these chromatographic conditions because of the
UV cut-off of the toluene-based mobile phase.
Injecting a 5 mg/L C60 solution showed no additional peaks, thus indicating the absence of
significant amounts of higher fullerenes or C60-oxides in the samples. Nevertheless, the injection of
an overloading C60 concentration (Figure 7A) shows at least six minor peaks (Figure 7A, insert I1)
eluting before the C60 peak. Based on their spectral features (Figure 7A, insert I2), these minor peaks
can be ascribed to some C60-oxides [39].
Figure 7B summarizes the comparison between the area/concentration ratios of each C60 sample.
With a precision of 5.8% (n = 6 obtained over three days), the HPLC analysis shows no significant
difference between the samples. Hence, the precision of this technique cannot provide a quantitative
comparison between the studied samples. This outcome agrees with those published previously [32].
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spectra of 1 to 6 peaks; (B) comparison between the peak area/C60-concentration ratios of the four
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3.2.3. GC-MS Analyses
As TGA and FTIR data clearly show the presence of volatile impurities, GC-MS was carried out in
order to identify these impurities.
Figure 8 shows the obtained GC-MS chromatographic profiles. They clearly show the presence of
several volatile impurities namely benzene, naphthalene, phthalate, and siloxane derivatives (Table 2).
These semi-quantitative analyses confirm the data obtained by the analyses in the solid state indicating
that the samples can be classified as a function of their purities as follow: S1 > S2 > S4 > S3. Notably,
the S3 and S4 samples contain significant amounts of xylene and toluene and some naphthalene
derivatives as compared to the S1 and S2 samples.
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Figure 8. GC-MS (gas chromatography–mass spectrometry) chromatograms of the four C60 samples
(T: toluene, Xy: xylene, S: siloxane derivative , Ph: phthalate derivatives).
Table 2. Detected impurities in the four C60 samples (semi-quantitative aspect; − absence; and + presence).
Impurity S1 S2 S3 S4
Toluene − + +++ +
Xylene − − +++ +++
Trimethyl benzene − − ± −
Tetra methyl benzene − + +++ −
Penta methyl benzene − − + −
Hexa methyl benzene − − + −
Hydroxylated toluene − − − +
Dichlorobenzene − − ± −
Methylbenzaldehyde − − + −
Hydroxymethylbenzoic acid − − + −
Naphthalene − − + −
Methylnaphthalene − − ++ ++
Dimethylnaphthalene − − + +
Trimethylnaphthalene − − + −
Tetramethylbiphenyl − − − +
Dibuthyl Phtalate ± + ± +++
Phthalic acid, isobuthyl octadecyl ester ++ +++ ± +++
Diethyl Phthalate ± ++ ± ++
Benzoic acid, 4-ethoxy-, ethyl ester − ++ − ++
Octamethylc clotetrasiloxane ++ − + −
Decamethylcyclopentasiloxane ++ + +++ +
Dodecamethylcyclohexasiloxane + + +++ ++
Tetradecamethylcycloheptasiloxane + +++ +++ ++
Hexadecamethylcyclooctasiloxane + +++ ± +++
Octadecamethylcyclononasiloxane + ++ − ++
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These data show that the GC-MS method can be used after appropriate calibration and validation
to quantify the residual solvents and other volatile impurities in a C60 sample.
4. Discussion
In order to perform successful clinical trials, the purity of an API must be guaranteed and so
does the purity of C60, which is already being sold for human consumption even if no official certified
procedure exists to verify its purity [16].
This paper contains a comprehensive analytical study of C60 samples, which has never been
carried out before. It illustrates the advantages and limitations of the techniques to characterize and
evaluate the purity of C60 samples.
While the physicochemical properties of C60 are well-known [7,10,22–27], until now only three
studies have been devoted to the purity analysis of C60 samples [31,32,42]. The first study conducted
more than 25 years ago concluded that C60 is prone to absorb solvents and oxygen, which may change
the properties of the sample, and that chemical reactions can occur with absorbed species even in the
dark [42]. After comparing the performances of several characterization techniques including fast
atomic bombardment (FAB—mass spectrometry, FTIR, UV-VIS spectrometry, and scanning electron
microscopy (SEM), the second study concluded that thermal analysis is a powerful technique for
analyzing the purity of C60 samples [31]. The third report, published eleven years later, concluded that
chromatographic analysis alone, as currently used in the certificates of C60 samples, is not sufficient for
detecting all impurities. According to the authors, it is necessary to use additional methods such as
mass spectrometry [32]. However, a straightforward purity criterion for C60 samples is still lacking
and no regulatory recommendations exist up to now.
The obtained data overall agree with previous studies [31,32,42]. They further show that DSC is
the most appropriate technique to establish a rapid and simple purity criterion for C60 samples based
on the sc-fcc transition temperature and enthalpy change (Tonset ≥ 258 K, ∆sc-fccH ≥ 8 J g−1).
Considered together, the results of the solid-state studies clearly show that samples S1 and S2
are the purest, whereas samples S3 and S4 contain some impurities. It is however not possible to
determine the identity of these impurities by the solid-state analytical methods, which will be carried
out with a further series of analytical methods.
FTIR provides a rapid assessment of the kind of impurities present in a C60 samples, in particular
because C60 itself contains only a limited number of FTIR absorption peaks; thus, impurity peaks are
quickly recognized.
GC-MS provides the most detailed picture of the various volatile molecular impurities that can be
found in the different C60 samples, whereas HPLC provides information on the presence of higher
fullerenes and oxidized fullerene species. Nonetheless, even the visual aspect of the C60 samples can
already provide clues about the quality of sample S3, which contains most kinds of impurities and is
least crystalline, possesses a brownish color, whereas the highly pure and crystalline samples S1 and
S2 have a black metallic appearance.
The next step is the verification of the innocuousness of C60 oily solutions and other C60-containing
preparations proposed by some companies for human consumption. Indeed, C60 oily solutions
prepared under some conditions may be harmful [43].
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Figure S1: Commentary written in 2004 by M.N. Rittner about the C60 toxicity, Figure S2: Energy dispersive
spectroscopy of the C60 samples S1–S4. S4b shows the presence of sulfur in some of the particles present in sample
S4, Figure S3: Energy dispersive fluorescence showing the presence of iron and traces of chromium and copper.
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